Literature DB >> 22020895

P. aeruginosa infection increases morbidity in experimental cholesteatomas.

Jae Y Jung1, Dong H Lee, Eric W Wang, Robert Nason, Toni M Sinnwell, Joseph P Vogel, Richard A Chole.   

Abstract

OBJECTIVES: Clinicians have long noted that infected cholesteatomas are more aggressive than uninfected ones without data to support these observations. The purpose of this study is to determine the etiological role of biofilm forming P. aeruginosa (PA) and the virulence factor, type IV pili (TFP), in the pathogenesis of experimental cholesteatomas.
DESIGN: We evaluated three different PA strains and one Escherichia coli strain in cholesteatoma progression: PA14, a well-characterized wound isolate, OPPA8, an otopathogenic strain from a human cholesteatoma, OPPA8-NP, an isogenic TFP deletion mutant, and DH5α, an E. coli strain.
METHODS: Cholesteatomas were induced in gerbils. We inoculated the right ear with bacteria and the left with vehicle. After 6 weeks their cholesteatomas were evaluated by micro-CT scanning. Cholesteatoma size and bone resorption were analyzed digitally.
RESULTS: Results demonstrate that PA infection increases cholesteatoma size when compared to uninfected controls: OPPA8 showed an 8.9-fold increase, PA14 a 2.6-fold increase, OPPA8-NP a 1.9-fold increase, while DH5α was not increased over controls. Additionally, infected bullae showed 10 to 50% more cholesteatoma-induced bone resorption.
CONCLUSIONS: In this model, PA infected cholesteatomas enlarge more rapidly and are more destructive than uninfected controls. OPPA8, the strain from a human cholesteatoma, showed the greatest enlargement and bone destruction. Additionally, we demonstrate that TFP is a virulence factor in this model because the nonpiliated isogenic mutant, OPPA8-NP, was significantly less aggressive than the wild-type OPPA8 indicating that type IV pili may be a virulence factor in this disease.
Copyright © 2011 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22020895      PMCID: PMC3359964          DOI: 10.1002/lary.22189

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  22 in total

1.  Interaction of Pseudomonas aeruginosa with A549 pneumocyte cells.

Authors:  E Chi; T Mehl; D Nunn; S Lory
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 2.  Cholesteatoma: a molecular and cellular puzzle.

Authors:  A P Albino; C P Kimmelman; S C Parisier
Journal:  Am J Otol       Date:  1998-01

3.  Mapping the surface regions of Pseudomonas aeruginosa PAK pilin: the importance of the C-terminal region for adherence to human buccal epithelial cells.

Authors:  K K Lee; P Doig; R T Irvin; W Paranchych; R S Hodges
Journal:  Mol Microbiol       Date:  1989-11       Impact factor: 3.501

4.  Bacterial flora in spontaneously occurring aural cholesteatomas in Mongolian gerbils.

Authors:  R S Fulghum; R A Chole
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

5.  Cholesteatoma. Experimental induction in the Mongolian Gerbil, Meriones Unguiculaus.

Authors:  M D McGinn; R A Chole; K R Henry
Journal:  Acta Otolaryngol       Date:  1982 Jan-Feb       Impact factor: 1.494

6.  Cholesteatoma: an epidemiologic study among members of kibbutzim in northern Israel.

Authors:  L Podoshin; M Fradis; Y Ben-David; A Margalit; A Tamir; L Epstein
Journal:  Ann Otol Rhinol Laryngol       Date:  1986 Jul-Aug       Impact factor: 1.547

7.  Alteration of the pilin adhesin of Pseudomonas aeruginosa PAO results in normal pilus biogenesis but a loss of adherence to human pneumocyte cells and decreased virulence in mice.

Authors:  M A Farinha; B D Conway; L M Glasier; N W Ellert; R T Irvin; R Sherburne; W Paranchych
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

Review 8.  Epidemiology of infections due to Pseudomonas aeruginosa.

Authors:  A J Morrison; R P Wenzel
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct

9.  Assembly and antigenicity of the Neisseria gonorrhoeae pilus mapped with antibodies.

Authors:  K T Forest; S L Bernstein; E D Getzoff; M So; G Tribbick; H M Geysen; C D Deal; J A Tainer
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

Review 10.  The role of anaerobic bacteria in otitis media: microbiology, pathogenesis, and implications on therapy.

Authors:  I Brook
Journal:  Am J Otolaryngol       Date:  1987 Mar-Apr       Impact factor: 1.808

View more
  10 in total

1.  Biofilm formation by otopathogenic strains of Pseudomonas aeruginosa is not consistently inhibited by ethylenediaminetetraacetic acid.

Authors:  Joseph Zenga; Patricia M Gagnon; Joseph Vogel; Richard A Chole
Journal:  Otol Neurotol       Date:  2012-08       Impact factor: 2.311

2.  Inactivation of specific Pseudomonas aeruginosa biofilm factors does not alter virulence in infected cholesteatomas.

Authors:  Richard A Chole; Patricia M Gagnon; Joseph P Vogel
Journal:  Otol Neurotol       Date:  2014-10       Impact factor: 2.311

3.  The contralateral ear in cholesteatoma.

Authors:  Sady Selaimen da Costa; Adriane Ribeiro Teixeira; Letícia Petersen Schmidt Rosito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-30       Impact factor: 2.503

4.  Lon Protease Has Multifaceted Biological Functions in Acinetobacter baumannii.

Authors:  Carly Ching; Brendan Yang; Chineme Onwubueke; David Lazinski; Andrew Camilli; Veronica G Godoy
Journal:  J Bacteriol       Date:  2018-12-20       Impact factor: 3.490

5.  FleQ, a Transcriptional Activator, Is Required for Biofilm Formation In Vitro But Does Not Alter Virulence in a Cholesteatomas Model.

Authors:  Wee Tin K Kao; Patricia M Gagnon; Joseph P Vogel; Richard A Chole
Journal:  Otol Neurotol       Date:  2016-08       Impact factor: 2.311

6.  Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study.

Authors:  Ravi N Samy; Brian R Earl; Noga Lipschitz; Ivy Schweinzger; Mark Currier; Timothy Cripe
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-10-15

Review 7.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

8.  TLR4 drives the pathogenesis of acquired cholesteatoma by promoting local inflammation and bone destruction.

Authors:  Yu Si; Yu Bin Chen; Sui Jun Chen; Yi Qing Zheng; Xiang Liu; Yi Liu; Huai Li Jiang; Guo Xu; Zhuo Hao Li; Qiu Hong Huang; Hao Xiong; Zhi Gang Zhang
Journal:  Sci Rep       Date:  2015-12-07       Impact factor: 4.379

Review 9.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

Review 10.  An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence.

Authors:  Charles D Morin; Eric Déziel; Jeff Gauthier; Roger C Levesque; Gee W Lau
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.